Compare
Assurant, Inc. vs Renaissancere Holdings Ltd vs Oscar Health, Inc. vs Brookfield Wealth Solutions Ltd.
| Latest fiscal year | Assurant, Inc. AIZ | Renaissancere Holdings Ltd RNR | Oscar Health, Inc. OSCR | Brookfield Wealth Solutions Ltd. BNT |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $12.81B | $12.85B | $11.70B | $11.63B |
| Revenue growth (YoY) | +7.9% | +9.9% | +27.5% | -17.5% |
| Gross margin | n/a | n/a | n/a | n/a |
| Operating margin | n/a | n/a | -3.4% | n/a |
| Net margin | 6.8% | 20.9% | -3.8% | 7.4% |
| Net income | $872.70M | $2.68B | -$443.15M | $863.00M |
| EPS (Diluted) | $16.93 | $56.03 | -$1.69 | n/a |
| Operating cash flow | $1.83B | $3.69B | $1.09B | $2.61B |
| Free cash flow | $1.60B | n/a | $1.06B | $2.54B |
| Cash & equivalents | $1.83B | $1.73B | $2.77B | $13.01B |
| Total assets | $36.29B | $53.80B | $6.33B | $157.18B |
| Total liabilities | $30.42B | $34.59B | $5.34B | $139.26B |
| Shareholders' equity | $5.87B | $11.61B | $980.74M | $17.92B |
| Return on year-end equity | 14.9% | 23.1% | -45.2% | 4.8% |
| Shares outstanding | 49.79M | 43.96M | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Assurant, Inc. | Renaissancere Holdings Ltd | Oscar Health, Inc. | Brookfield Wealth Solutions Ltd. |
|---|---|---|---|---|
| Latest | $12.81B Ended 2025-12-31 | $12.85B Ended 2025-12-31 | $11.70B Ended 2025-12-31 | $11.63B Ended 2025-12-31 |
| 1 year earlier | $11.88B Ended 2024-12-31 | $11.70B Ended 2024-12-31 | $9.18B Ended 2024-12-31 | $14.10B Ended 2024-12-31 |
| 2 years earlier | $11.13B Ended 2023-12-31 | $9.13B Ended 2023-12-31 | $5.86B Ended 2023-12-31 | $6.91B Ended 2023-12-31 |
| 3 years earlier | $10.19B Ended 2022-12-31 | $5.06B Ended 2022-12-31 | $3.96B Ended 2022-12-31 | $4.41B Ended 2022-12-31 |
| 4 years earlier | $10.19B Ended 2021-12-31 | $5.28B Ended 2021-12-31 | $1.84B Ended 2021-12-31 | $1.04B Ended 2021-12-31 |